Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | Biomarker | disease | BEFREE | These studies demonstrate that HLA-B*27:02 mediates protection against HIV disease progression that is at least as strong as or stronger than that mediated by HLA-B*27:05. | 29167337 | 2018 | ||||
|
0.090 | Biomarker | disease | BEFREE | Furthermore, the HLA-B*14-associated protection against HIV disease progression is significantly greater for HLA-B*14:02 than for HLA-B*14:01, consistent with the superior antiviral efficacy of the HLA-B*14-EL9 response. | 28878089 | 2017 | ||||
|
0.090 | Biomarker | disease | BEFREE | The precise immune responses mediated by HLA class I molecules such as HLA-B*27:05 and HLA-B*57:01 that protect against HIV disease progression remain unclear. | 26123575 | 2015 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | We sought to determine the role of HLA-B allele frequency on rapid HIV disease progression. | 25746818 | 2015 | ||||
|
0.090 | Biomarker | disease | BEFREE | HLA-B*57:01 and HLA-B*57:03, the most prevalent HLA-B*57 subtypes in Caucasian and African populations, respectively, are the HLA alleles most protective against HIV disease progression. | 24501417 | 2014 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression. | 23103378 | 2013 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | Our study highlighted independent effects of HLA-B and HLA-C alleles on HIV-disease progression. | 23462218 | 2013 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | Genetic variation within the HLA-B locus has the strongest impact on HIV disease progression of any polymorphisms within the human genome. | 22896606 | 2012 | ||||
|
0.090 | GeneticVariation | disease | BEFREE | The analysis revealed complete linkage disequilibrium between HCP5 and HLA-B*5701/HLA-Cw*06, a modest effect of 5' HLA-C on viral set point in the absence of HLA-B*5701, and no influence of the RNF39 /ZNRD1 extended haplotype on HIV disease progression. | 19693088 | 2009 |